KEGG: ath:AT1G01500
UniGene: At.27718
At1g01500 is an Arabidopsis thaliana protein classified within the Erythronate-4-phosphate dehydrogenase family. Located on chromosome 1 at position 185260-186573 in the forward direction, this protein consists of 327 amino acids in length . The gene encoding At1g01500 is one of approximately 29,454 predicted genes in the Arabidopsis genome, which has been extensively studied through insertional mutagenesis techniques . As a member of the Erythronate-4-phosphate dehydrogenase family, this protein likely plays a role in carbohydrate metabolism pathways, though many aspects of its specific function remain to be fully characterized.
At1g01500 has been identified and characterized primarily through genome-wide insertional mutagenesis studies of Arabidopsis thaliana. Large-scale T-DNA insertion projects have generated more than 225,000 independent insertion events throughout the Arabidopsis genome, with precise locations determined for over 88,000 of these insertions . Through these comprehensive genomic approaches, mutations have been identified in more than 21,700 Arabidopsis genes, including At1g01500 . Genome-wide analysis has revealed interesting patterns in the distribution of these integration events, with significant biases observed at both chromosome and gene levels . When studying At1g01500, researchers typically reference these large-scale genomic resources to understand the gene's context within the broader Arabidopsis genome.
Sequence analysis indicates that At1g01500 shares homology with proteins in other plant species, as demonstrated by BLAST results showing similarity to transcript comp15365_c0_seq1 in Sesbania sesban with a significant E-value of 8e-30 . The alignment between these sequences has a score of 110, occurring in the +3 reading frame . This level of conservation suggests that At1g01500 likely performs an evolutionarily conserved function across different plant species. When conducting comparative genomic analyses, researchers should consider examining orthologous proteins in other model and non-model plant systems to gain insights into functional conservation and potential specialized roles in different plant lineages.
For recombinant At1g01500 production, researchers have multiple expression system options, each with distinct advantages depending on experimental requirements. Common expression systems include:
| Expression System | Advantages | Considerations |
|---|---|---|
| E. coli (BL21(DE3), JM115, Rosetta-GAMI) | Rapid growth, high yield, cost-effective | May lack post-translational modifications |
| Yeast (SMD1168, GS115, X-33) | Eukaryotic modifications, moderate yield | Longer production timeline than bacteria |
| Insect cells (Sf9, Sf21, High Five) | Complex eukaryotic modifications | Higher cost, specialized equipment needed |
| Mammalian cells (293, 293T, NIH/3T3, COS-7, CHO) | Most authentic post-translational modifications | Highest cost, lowest yield, longest timeline |
Selection should be based on research needs, with E. coli systems providing efficient production for structural studies, while eukaryotic systems may be preferable when authentic folding and modifications are essential for functional analysis . When expressing plant proteins like At1g01500 in heterologous systems, codon optimization is often necessary to enhance expression levels in the host organism.
Purification of recombinant At1g01500 typically involves a multi-step process designed to maximize yield, purity, and biological activity. The approach should begin with the selection of appropriate fusion tags to facilitate purification. Common options include:
Tag positioning: Consider both N-terminal and C-terminal positioning to determine optimal accessibility
Purification protocol sequence:
Initial capture via affinity chromatography based on the selected tag
Secondary purification using ion exchange chromatography
Polishing step with size exclusion chromatography for highest purity
For optimal results, researchers should conduct small-scale pilot studies to identify potential solubility issues and optimize buffer conditions before scaling up production . Depending on experimental requirements, additional processing steps such as tag removal, endotoxin removal, and filtration sterilization may be necessary . Quality control should include SDS-PAGE and Western blot analysis to confirm protein identity, purity, and integrity.
Enhancing the solubility of recombinant At1g01500 requires systematic optimization of multiple parameters throughout the expression and purification process. Key strategies include:
Fusion partner selection: MBP (maltose-binding protein) and thioredoxin (trxA) tags significantly enhance solubility compared to simple His-tags
Expression conditions optimization:
Reduce induction temperature (16-20°C)
Lower inducer concentration
Extend expression duration at reduced temperatures
Buffer optimization:
Screen additives (glycerol, arginine, detergents)
Test various pH conditions
Include stabilizing agents appropriate for dehydrogenase family proteins
If the protein expresses primarily as inclusion bodies despite optimization efforts, refolding protocols can be implemented to recover soluble, active protein . The refolding process typically involves solubilization of inclusion bodies with denaturants followed by gradual removal of the denaturant through dialysis or dilution while maintaining conditions that prevent aggregation.
Designing effective insertion mutants for At1g01500 requires strategic planning based on genomic structure and protein domains. Researchers should:
Analyze the gene structure to identify critical exons, particularly those encoding functional domains of the Erythronate-4-phosphate dehydrogenase family
Reference existing T-DNA insertion collections, which contain mutations in over 21,700 Arabidopsis genes
Design insertion strategies targeting:
Promoter regions (for expression modulation)
Early exons (for complete knockout)
Specific domains (for targeted functional disruption)
Employ CRISPR-Cas9 approaches for precise modifications when conventional T-DNA insertions are insufficient
When analyzing the resulting mutants, researchers should implement thorough genotyping protocols to confirm insertion positions, followed by RT-PCR and Western blot analyses to verify disruption of transcript and protein expression. Phenotypic characterization should include comprehensive metabolic profiling, focusing on pathways involving erythronate-4-phosphate, as well as general plant development and stress response parameters.
Investigating protein-protein interactions involving At1g01500 requires a multi-faceted approach combining both in vitro and in vivo techniques to generate comprehensive and reliable interaction data. Recommended methodologies include:
Yeast two-hybrid (Y2H) screening:
Construct bait plasmids containing At1g01500 fused to DNA-binding domains
Screen against Arabidopsis cDNA libraries
Validate positive interactions through targeted assays
Co-immunoprecipitation (Co-IP) studies:
Express tagged versions of At1g01500 in plant tissues
Immunoprecipitate protein complexes using tag-specific antibodies
Identify co-precipitated proteins via mass spectrometry
Bimolecular fluorescence complementation (BiFC):
Generate fusion constructs with split fluorescent protein fragments
Co-express in plant cells to visualize interactions in native cellular contexts
Analyze subcellular localization of interaction complexes
Proximity-based labeling approaches:
Fuse At1g01500 with enzymes like BioID or APEX2
Identify proximal proteins through biotinylation and subsequent purification
Distinguish between direct interactors and proteins in the same complex
Each method has specific strengths and limitations, so combining multiple approaches provides the most robust interaction data for functional interpretation.
Characterizing the structure of At1g01500 presents unique challenges that can be addressed through complementary structural biology approaches:
Designing robust enzymatic activity assays for At1g01500 requires careful consideration of its predicted function as an Erythronate-4-phosphate dehydrogenase family protein. A comprehensive approach should include:
Substrate preparation:
Synthesize or source pure Erythronate-4-phosphate
Prepare related metabolites for specificity testing
Include appropriate cofactors (likely NAD+ or NADP+)
Assay development:
Monitor NAD(P)H formation spectrophotometrically at 340nm
Design coupled enzyme assays if direct product detection is challenging
Optimize reaction conditions (pH, temperature, buffer composition)
Kinetic analysis:
Determine Km and Vmax parameters through Michaelis-Menten kinetics
Evaluate potential inhibitors and activators
Assess substrate specificity using structural analogs
Controls and validation:
Include enzyme-free and substrate-free controls
Test catalytically inactive mutants (generated by site-directed mutagenesis)
Compare activity with related enzymes from other organisms
When interpreting results, researchers should consider the possibility that At1g01500 may have evolved substrate specificities that differ from canonical Erythronate-4-phosphate dehydrogenases, potentially indicating specialized metabolic roles in Arabidopsis.
Investigating the physiological role of At1g01500 in Arabidopsis requires a comprehensive phenotypic analysis of plants with altered expression levels, combined with molecular and biochemical characterization:
Genetic resources development:
Identify and characterize T-DNA insertion lines disrupting At1g01500
Generate overexpression lines using constitutive and tissue-specific promoters
Create complementation lines to confirm phenotype-genotype relationships
Phenotypic analysis across developmental stages:
Document growth parameters under standard conditions
Assess responses to various abiotic stresses (drought, salt, temperature extremes)
Evaluate metabolic profiles using targeted and untargeted metabolomics
Gene expression analysis:
Determine tissue-specific and developmental expression patterns
Identify conditions that regulate At1g01500 expression
Perform transcriptome analysis to identify co-regulated genes
Subcellular localization:
Generate fluorescent protein fusions to determine compartmentalization
Perform biochemical fractionation to confirm localization
Identify potential organelle-specific functions
Integration of these diverse datasets will provide a comprehensive understanding of At1g01500's role in plant metabolism and development, potentially revealing unexpected functions beyond its predicted enzymatic activity.
When encountering contradictory results in At1g01500 functional studies, researchers should implement a systematic approach to resolve discrepancies:
Methodological comparison:
Rigorously examine differences in experimental protocols
Consider genetic background variations in plant materials
Evaluate environmental conditions that might influence results
Statistical reanalysis:
Apply appropriate statistical methods for the specific data types
Consider sample size limitations and power analysis
Implement more robust statistical approaches when appropriate
Independent validation:
Use complementary techniques to verify key findings
Collaborate with independent laboratories for replications
Consider different genetic backgrounds or ecotypes
Biological context integration:
Evaluate whether contradictions reflect context-dependent functions
Consider redundancy with related genes that may mask phenotypes
Investigate potential post-transcriptional or post-translational regulation
Literature meta-analysis:
Systematically compare methodologies across published studies
Identify patterns in contradictory findings
Develop unifying hypotheses that account for apparently conflicting results
By approaching contradictions as opportunities for deeper investigation rather than obstacles, researchers can develop more nuanced and accurate models of At1g01500 function.
Designing experiments to study At1g01500 regulation requires a multi-layered approach addressing transcriptional, post-transcriptional, and post-translational mechanisms:
Transcriptional regulation:
Promoter analysis: Clone the At1g01500 promoter (1-2kb upstream) into reporter constructs
Identify transcription factor binding sites through bioinformatic analysis
Perform chromatin immunoprecipitation (ChIP) to confirm direct binding
Test promoter activity under various conditions and in different tissues
Post-transcriptional regulation:
Analyze mRNA stability under different conditions
Investigate alternative splicing patterns
Identify potential regulatory small RNAs through computational prediction and validation
Post-translational regulation:
Map modification sites (phosphorylation, ubiquitination, etc.) through mass spectrometry
Investigate protein turnover rates using cycloheximide chase assays
Generate modification-site mutants to assess functional consequences
Environmental response profiling:
Monitor expression changes in response to hormones, stresses, and developmental cues
Correlate protein abundance with transcript levels to identify translational control
Integrate data from public repositories to identify conditions affecting At1g01500
This comprehensive approach will reveal the regulatory networks controlling At1g01500 expression and activity, providing insights into its physiological roles and potential biotechnological applications.
The analysis of experimental data relating to At1g01500 requires carefully selected statistical approaches appropriate to the specific experimental design and data characteristics:
For gene expression comparisons:
Use paired t-tests for before/after comparisons within the same samples
Apply ANOVA for multi-condition comparisons with post-hoc tests (Tukey, Bonferroni)
Implement non-parametric alternatives (Mann-Whitney, Kruskal-Wallis) when normality cannot be assumed
For phenotypic analyses:
Perform repeated measures ANOVA for time-course experiments
Use mixed-effects models to account for random factors
Apply multivariate approaches for correlated phenotypic traits
For protein-protein interaction data:
Implement statistical filtering to distinguish true interactions from background
Use clustering algorithms to identify interaction networks
Apply enrichment analyses to characterize interacting proteins functionally
For metabolomic studies:
Use principal component analysis (PCA) to identify major patterns
Apply partial least squares discriminant analysis (PLS-DA) for supervised classification
Implement pathway enrichment analysis to contextualize metabolic changes
When designing experiments, researchers should conduct power analyses to determine appropriate sample sizes and include biological replicates (typically n≥3) to ensure robust statistical inference. Publication of complete datasets and transparent reporting of statistical methods enhances reproducibility and facilitates meta-analyses.
Formulating effective research questions about At1g01500 requires careful consideration of question type, scope, and methodological approach. Well-designed research questions should:
Be specific and focused to allow for clear experimental design and interpretation
Be relevant to broader biological concepts while remaining precisely targeted to At1g01500
Be testable through available methodologies and within practical constraints
Avoid simple yes/no answers, instead requiring analytical approaches and data interpretation
Examples of well-formulated research questions for At1g01500 studies include:
| Research Question Type | Example Formulation |
|---|---|
| Correlational | What is the relationship between At1g01500 expression levels and drought tolerance in Arabidopsis? |
| Exploratory | How does the interactome of At1g01500 differ between root and shoot tissues? |
| Explanatory | What mechanisms regulate the enzymatic activity of At1g01500 during phosphate starvation? |
The most productive research questions often emerge from preliminary data or observations that suggest unexpected patterns or relationships . Building questions that connect At1g01500 to broader biological processes or that explore its role in responding to environmental challenges can enhance the impact and significance of the research.
Several cutting-edge technologies hold particular promise for advancing our understanding of At1g01500 function:
Single-cell transcriptomics and proteomics:
Reveal cell-type specific expression patterns
Identify rare cell populations where At1g01500 may play critical roles
Map expression dynamics during development at unprecedented resolution
Genome editing technologies:
CRISPR-Cas base editing for precise manipulation without double-strand breaks
Prime editing for targeted insertions, deletions, and all possible point mutations
Conditional gene regulation systems for temporal and spatial control
Structural biology advancements:
AlphaFold2 and related AI systems for structure prediction
Cryo-electron tomography for in situ structural visualization
Integrative structural biology combining multiple experimental approaches
Metabolic flux analysis:
13C labeling combined with metabolomics to track carbon flow
Flux balance analysis to model metabolic network perturbations
Integration with genome-scale metabolic models
Systems biology approaches:
Multi-omics data integration frameworks
Network analysis to position At1g01500 in broader regulatory contexts
Machine learning applications for phenotype prediction from molecular data
By applying these emerging technologies to At1g01500 research, scientists can develop more comprehensive and mechanistic understandings of its functions in plant metabolism and physiology.
Despite advances in Arabidopsis genomics and proteomics, several fundamental questions about At1g01500 remain unanswered:
Physiological substrate specificity:
What is the true in vivo substrate of At1g01500 in Arabidopsis?
How does substrate preference compare with homologs in other species?
Are there secondary enzymatic activities beyond its annotated function?
Regulatory networks:
What transcription factors directly control At1g01500 expression?
How is At1g01500 integrated into stress response pathways?
What post-translational modifications regulate its activity?
Evolutionary significance:
How conserved is At1g01500 function across plant lineages?
Has subfunctionalization occurred in species with multiple paralogs?
What selective pressures have shaped its evolution?
Metabolic integration:
How does At1g01500 activity influence broader metabolic networks?
What compensatory mechanisms exist when At1g01500 function is compromised?
How does its activity coordinate with related metabolic enzymes?
Biotechnological potential:
Could modulation of At1g01500 enhance plant stress tolerance?
Might At1g01500 serve as a target for improving specific plant traits?
What industrial applications might utilize At1g01500 enzymatic properties?
Addressing these questions will require integrative approaches combining molecular, biochemical, and systems biology methodologies.